Pure Invest Now – Page 303

Arcellx stock (NASDAQ: ACLX) climbed roughly 80% in premarket trade on Monday after Gilead Sciences agreed to buy the cancer-therapy developer in a $7.8 billion all-cash deal.The stock’s…

MidEast energy output loss may take 2 years to recover: IEA

Evening digest: Trump Iran deal hopes rise, oil climbs on risks

Dovish Fed official turns cautious as energy shock lifts inflation risks

Editor's Pick

Investing

Why is Arcellx stock up 80% today? Gilead’s $7.8B answer

Stock

Economy

Popular News

USD/MXN forecast after the final Mexico Central Bank rate cut

Titan reports lower-than-expected Q4 profit amid higher gold prices

Latest

Explainer: why Trump wants defense companies to cut stock buybacks and dividends

Commodity wrap: gold, silver fall; oil steady as US strikes Venezuelan oil deal

Storm Goretti paralyses Europe: snow chaos halts flights, trains, and buses

US private sector adds 41,000 jobs in December, ADP shows

Chronicles of Caracas from the ground: blackouts, blasts, and empty shelves

Softening UK jobs market paves way for BoE rate cut in March, says ING Group

USD/MXN forecast after the final Mexico Central Bank rate cut

Titan reports lower-than-expected Q4 profit amid higher gold prices